Refine
Has Fulltext
- yes (98)
Is part of the Bibliography
- yes (98)
Year of publication
- 2015 (98) (remove)
Document Type
- Journal article (61)
- Doctoral Thesis (37)
Keywords
- cancer (4)
- membrane proteins (4)
- Aspergillus fumigatus (3)
- Vaccinia-Virus (3)
- biodiversity (3)
- gene (3)
- honeybee (3)
- in vitro (3)
- mushroom body (3)
- olfaction (3)
- Angiogenese (2)
- Biene (2)
- Biologische Uhr (2)
- CD8 (2)
- Candida albicans (2)
- Dendritische Zelle (2)
- Drosophila (2)
- Drosophila melanogaster (2)
- ELISPOT (2)
- Humangenetik (2)
- Inhibition (2)
- Krebs <Medizin> (2)
- Mesenchymzelle (2)
- Myc (2)
- RNA-Seq (2)
- Taufliege (2)
- active zone (2)
- avoidance learning (2)
- bees (2)
- bumblebees (2)
- butterflies (2)
- cytoskeleton (2)
- dendritic cells (2)
- ecosystem services (2)
- evolution (2)
- expression (2)
- fluorescent probes (2)
- growth (2)
- insects (2)
- leaf-cutting ants (2)
- localization microscopy (2)
- melanoma (2)
- metabolism (2)
- microarray (2)
- microglomeruli (2)
- neurotransmitter release (2)
- next generation sequencing (2)
- resistance (2)
- synaptic plasticity (2)
- virulence (2)
- "-omics" (1)
- 2-APB (1)
- 3-dimensional structure (1)
- ANOVA (1)
- Acromyrmex ambiguus (1)
- Acyrthosiphon pisum (1)
- Adenosin (1)
- Adipogenesis (1)
- Amyotrophe Lateralsklerose (1)
- Angiogenesis (1)
- Antigen CD8 (1)
- Apoptose (1)
- Apoptosis (1)
- Arachidonsäure (1)
- Arbeitsteilung (1)
- Astrozyten (1)
- Aurora-A (1)
- Ausbreitung (1)
- Australian stingless bees (1)
- Axonal degeneration (1)
- BH3 domains (1)
- Bakterielle Infektion (1)
- Bauchspeicheldrüsenkrebs (1)
- Bcl-2 proteins (1)
- Behandlungsoption (1)
- Bienen <Familie> (1)
- BioID (1)
- Bone marrow stromal cell (BMSC) (1)
- Bruchpilot (1)
- C. elegans (1)
- CD39 (1)
- CD4 (1)
- CD4+T cells (1)
- CD73 (1)
- CD8+T cells (1)
- CNTF (1)
- CTL function (1)
- CaMKII (1)
- Ca\(^{2+}\) channels (1)
- Caenorhabditis elegans (1)
- ChIP-sequencing (1)
- Chlamydia (1)
- Chlamydia trachomatis (1)
- Ciliary neurotrophic factor (1)
- Circadian clock (1)
- Circadiane Rhythmen (1)
- Co-option (1)
- Costa Rica (1)
- Cynoglossus semilaevis (1)
- Cytotoxizität (1)
- DMRT1 (1)
- DNA Mismatch repair (1)
- DNA barcoding (1)
- DNA damage (1)
- DNA methylation (1)
- DNA-Sequenz (1)
- DNA-binding proteins (1)
- DNS-Reparatur (1)
- Darmflora (1)
- Demökologie (1)
- Diabetic polyneuropathy (1)
- Diagnostik (1)
- Dickdarmkrebs (1)
- Differentiation (1)
- Division of labor (1)
- EPC (1)
- Eierstockkrebs (1)
- Eierstocktumor (1)
- Eisenoxidnanopartikel (1)
- Elongation (Transkription) (1)
- Endothel (1)
- Epigenetik (1)
- Epimutationen (1)
- Erbkrankheit (1)
- FANCO (1)
- Fanconi Anämie (1)
- Fettgewebsstammzellen (1)
- Fettzelle (1)
- Fibroblastenwachstumsfaktor (1)
- Foxp3 (1)
- Fragmentierung (1)
- Französische Feldwespe (1)
- Gen (1)
- Genetic engineering (1)
- Genexpression (1)
- Geschützte Natur (1)
- Glioblastom (1)
- Governance (1)
- HHblits (1)
- HIF-1α (1)
- HLA-G (1)
- Habitat (1)
- Halobacterium halobium (1)
- HeLa cells (1)
- Heuschrecken <Überfamilie> (1)
- Homoptera aphididae (1)
- Honeybee (1)
- Honigbiene (1)
- Host cell death (1)
- Human Host (1)
- Hydrogel (1)
- Hydrogele (1)
- Hymenoptera (1)
- Hypoxie (1)
- Hämatopoese (1)
- I-tasser (1)
- IFN-γ (1)
- III adenylyl cyclases (1)
- III secretion (1)
- III secretion system (1)
- IL-17 (1)
- IL-2 (1)
- IL-4 (1)
- IL-5 (1)
- ITS2 (1)
- Immune (1)
- Immunologie (1)
- Immunsuppression (1)
- Immunsystem (1)
- Infertilität (1)
- Inhibitor (1)
- Innere Uhr (1)
- Intracellular replication (1)
- Johnstons organ (1)
- Kehlkopf (1)
- Killerzelle (1)
- Knochenregeneration (1)
- Knockout <Molekulargenetik> (1)
- LC-MS/MS (1)
- LINC complex (1)
- Landouzy-Déjerine-Atrophie (1)
- Landschaftsökologie (1)
- Laufkäfer (1)
- Legionella (1)
- Lernen (1)
- MAP-Kinase (1)
- MAPK (1)
- MITF (1)
- MORN-repeat (1)
- MRSA (1)
- MSC (1)
- MYCN (1)
- MYCN-amplified (1)
- Magerrasen (1)
- Maus (1)
- Melanom (1)
- Melanomzellen (1)
- Mesenchymale Stammzelle (1)
- Messenger-RNP (1)
- Messenger-RNS (1)
- Metagenom (1)
- Metastase (1)
- Mikroglia (1)
- Mismatch (1)
- Mitogen-aktivierte Proteinkinase (1)
- Miz1 (1)
- Molekularbiologie (1)
- Molekulargenetik (1)
- Mosaik (1)
- Motoneuron (1)
- Motoneuronenerkrankung (1)
- Motor nerve biopsy (1)
- Multiples Myelom (1)
- Mutation (1)
- Myatrophische Lateralsklerose (1)
- Myc Transcription (1)
- Mycobacterium (1)
- Mycobacterium tuberculosis (1)
- Myotonische Dystrophie (1)
- N-Myc (1)
- NF-κB (1)
- NFAT (1)
- NGS (1)
- NVP-BEZ235 (1)
- Nestbau (1)
- Neuroblastom (1)
- Neuroblastoma (1)
- Neuronal plasticity (1)
- Neuronale Plastizität (1)
- Neuropathy (1)
- Neurotrophic factors (1)
- Next Generation Sequencing (1)
- Nisthilfe (1)
- Normal Distribution (1)
- Oncolytic Vaccinia Virus Therapy (1)
- Onkolyse (1)
- Onkolytische Vaccinia Virustherapie (1)
- Osteogenesis (1)
- Osteoporose (1)
- Pan-Raf-Inhibition (1)
- Participation (1)
- Period (1)
- Peroxiredoxin (1)
- Peroxiredoxin 6 (1)
- Phagosom (1)
- Phagosomal escape (1)
- Phagozytose (1)
- Pheromon (1)
- Pheromon Kommunikation (1)
- Pheromon communication (1)
- Phosphorylierung (1)
- Plasmozytom (1)
- Polistes (1)
- Populationsgenetik (1)
- Prostaglandin E2 (1)
- Proteasomaler Abbau (1)
- Protected Area (1)
- RAD51C (1)
- RNA binding proteins (1)
- RNAi (1)
- RNS-Interferenz (1)
- RNS-Polymerase II (1)
- Raf-Kinasen (1)
- Rapsanbau (1)
- Regulatorischer T-Lymphozyt (1)
- Remission (1)
- Repression (1)
- Reversion (1)
- SOX9 (1)
- STAT3 (1)
- SUN domain proteins (1)
- Salmonella (1)
- Salmonella-containing vacuole (SCV) (1)
- Sekundärwald (1)
- Shaggy (1)
- Simkania (1)
- Simkania negevensis (1)
- South Korea (1)
- Squalius alburnoides (1)
- Stammzelle (1)
- Staphylococcus aureus (1)
- Sterilität (1)
- Strahlensensibilisator (1)
- Strahlentherapie (1)
- T cells (1)
- T-cells (1)
- TLR7 (1)
- TLR8 (1)
- TbMORN1 (1)
- Therapie (1)
- Therapy (1)
- Thermoregulation (1)
- Thrombozyt (1)
- Timeless (1)
- Tissue Engineering (1)
- Toll-like-Rezeptoren (1)
- Transkription <Genetik> (1)
- Transkriptionsfaktor (1)
- Trypanosoma brucei (1)
- Tumorerkrankungen (1)
- Tumorzelle (1)
- Ubiquitinierung (1)
- V-antigen (1)
- Vascular endothelial Growth Factor (1)
- Vorläuferzelle (1)
- W Arly Pendjari WAP (1)
- WH2 domain (1)
- Wespen (1)
- West Africa (1)
- Westafrika (1)
- Wilms tumour (1)
- Wirtszelle (1)
- Xiphophorus (1)
- Y chromosome (1)
- Yersinia enterocolitica (1)
- Zelltod (1)
- \(\alpha\)-latrotoxin (1)
- abundance (1)
- acromyrmex ambiguus (1)
- actin nucleation (1)
- action potentials (1)
- acts downstream (1)
- adaptive growth (1)
- adipocytes (1)
- agent-based model (1)
- agricultural intensification (1)
- agricultural landscapes (1)
- agroecosystems (1)
- algorithm (1)
- alignment (1)
- alpha-toxin (1)
- alzheimers disease (1)
- angeborenes Immunsystem (1)
- angiogenesis (1)
- animal migration (1)
- animal sexual behavior (1)
- antagonist (1)
- antennal lobe (1)
- antimicrobial peptides (1)
- apis mellifera (1)
- apixaban (1)
- apoptosis (1)
- arachidonic acid (1)
- armyworm Lepidoptera (1)
- assemblages (1)
- axonaler Transport (1)
- bacterial invasion (1)
- bacterial pathogens (1)
- bacteriorhodopsin (1)
- bacterium Legionella pneumophila (1)
- bagworms Lepidoptera (1)
- balance hypothesis (1)
- bark beetles (1)
- bax (1)
- beetle horns (1)
- behavior (1)
- behavioral conditioning (1)
- beta-catenin (1)
- beta-diveristy (1)
- beta-lactamase inhibition (1)
- biased dispersal (1)
- binding (1)
- biodiversity conservation (1)
- biodiversity-ecosystem functioning (1)
- biofilm formation (1)
- bioinformatics and computational biology (1)
- biological control (1)
- biological pest control (1)
- biology (1)
- biomaterial surfaces (1)
- body-size (1)
- bone regeneration (1)
- cabbage Brassica oleracea var. capitata (1)
- calcareous grassland (1)
- calpain (1)
- camponotus floridanus (1)
- candida genome database (1)
- capture-mark-recapture (1)
- carbon dioxide avoidance (1)
- carbonaria (1)
- carpenter ant (1)
- carrying capacity (1)
- cell fate (1)
- cell membranes (1)
- cell proliferation (1)
- cell size (1)
- cell wall (1)
- cells (1)
- cellular camp (1)
- cellular senescence (1)
- centrality (1)
- channelrhodopsin-2 (1)
- chlamydia (1)
- chlamydia infection (1)
- chlamydia trachomatis (1)
- chondrosarcoma (1)
- chordotonal organs (1)
- circadian rhythms (1)
- climate change (1)
- clock reproduction ecology (1)
- co-immunoprecipitation (1)
- coincidence (1)
- color discrimination (1)
- communities (1)
- community composition (1)
- community functional-responses (1)
- compartment boundary (1)
- complex (1)
- complex networks (1)
- complex traits (1)
- compound eye (1)
- computational prediction (1)
- computational systems biology (1)
- contributes (1)
- control profiles (1)
- copy number (1)
- crop harvest (1)
- crystal structure (1)
- cuticular profiles (1)
- cytokine profiling (1)
- cytokines (1)
- cytokinesis (1)
- c‐Myc (1)
- dSTORM (1)
- database (1)
- day length (1)
- death pathway sar locus (1)
- decay (1)
- decline (1)
- defense and evasion strategies (1)
- defenses (1)
- degradation (1)
- determination locus (1)
- determining genes (1)
- diagnostic accuracy (1)
- differentially expressed genes (1)
- differentiation (1)
- diffraction limit (1)
- direct oral anticoagulants (1)
- direct thrombin inhibitor (1)
- discovery (1)
- dispersal (1)
- disruption project (1)
- diversity (1)
- division of labor (1)
- domain (1)
- drosophila larvae (1)
- dynamics (1)
- ecology (1)
- electrolytes (1)
- encephalitis dementia (1)
- endocytic multivesicular bodies (1)
- endoplasmic reticulum (1)
- endothelial cells (1)
- enteric pathogens (1)
- enterica serovar Typhimurium (1)
- envelopment (1)
- epithelial cells (1)
- eucalyptus (1)
- eukaryotic gene expression (1)
- european beech forests (1)
- european countries (1)
- excitation-secretion coupling (1)
- exome (1)
- expression analysis (1)
- factor B (1)
- factor XA inhibitor (1)
- family (1)
- fish (1)
- fishes Xiphophorus (1)
- flagellar motility (1)
- flies (1)
- flow (1)
- flowers (1)
- fluorescence microscopy (1)
- format (1)
- fruit set (1)
- functional analysis (1)
- functional modules (1)
- fungal pathogens (1)
- gain (1)
- gastrointestinal cancer (1)
- gating (1)
- gene expression (1)
- gene ontology (1)
- gene regulator agr (1)
- genetics (1)
- genome (1)
- genome browser (1)
- genome cells (1)
- genus Xiphophorus (1)
- geprägte Gene (1)
- glial cells (1)
- glycerol (1)
- gonopodium (1)
- growth and differentiation factor 5 (1)
- guides (1)
- habitats (1)
- hearing (1)
- herbivores (1)
- herbivorous insects (1)
- heterogamety (1)
- heterogenity (1)
- heterosis (1)
- high throughput sequencing (1)
- histology (1)
- honey bees (1)
- host cells (1)
- host pathogen interactions (1)
- host-pathogen adaption (1)
- host-pathogen interaction (1)
- human african trypanosomiasis (1)
- human immune system (1)
- human immunodeficiency virus (1)
- human melanoma (1)
- humane Keimzellen (1)
- hybrid origin (1)
- hybridization (1)
- hybrids (1)
- hymenoptera (1)
- hypotonic (1)
- hypotonic solutions (1)
- hypoxia-independent (1)
- hämatopoetisches Mosaik (1)
- illumina MiSeq platform (1)
- illumination microscopy (1)
- imaginal disk (1)
- immune escape (1)
- immune system (1)
- immuno-magnetic purification (1)
- immunological cross-talk (1)
- immunoprecipitation (1)
- import (1)
- in vivo (1)
- infection (1)
- insect (1)
- insect populations (1)
- insect timing (1)
- instinct (1)
- integrative genomics viewer (1)
- interolog (1)
- intracellular bacteria (1)
- intracellular pH (1)
- intracellular replication (1)
- isotonic (1)
- isotopolog profiling (1)
- kappa-B (1)
- key innovation (1)
- land use intensification (1)
- land-use intensity (1)
- landscape ecology (1)
- learning (1)
- learning and memory (1)
- life span (1)
- ligand CD55 (1)
- ligand-receptor complex (1)
- linkage map (1)
- long-distance dispersal (1)
- mRNA metabolism (1)
- maize (1)
- male-specific traits (1)
- males emerge (1)
- managed grasslands (1)
- management (1)
- mating success (1)
- melanogenesis (1)
- melanoma cells (1)
- membrane potential (1)
- membrane receptor signaling (1)
- memory (1)
- memory immune responses (1)
- metaanalysis (1)
- metagenomic (1)
- metastasis (1)
- metastatic melanoma (1)
- mice (1)
- microbial rhodopsins (1)
- mitochondria (1)
- mitochondrial membrane (1)
- models (1)
- modulates virulence (1)
- molecular cloning (1)
- monoclonal antibodies (1)
- morphogenetic furrow progression (1)
- mortality rates (1)
- moths and butterflies (1)
- motor proteins (1)
- mouse model (1)
- mouse testis differentiation (1)
- multi-electrode-recording (1)
- multiparticle collision dynamics (1)
- mutants (1)
- mutation (1)
- native bees (1)
- natural enemies (1)
- natural variation (1)
- nectar (1)
- nesting behaviour (1)
- network inference (1)
- networks (1)
- neuromuscular junction (1)
- neurons (1)
- nitric oxide (1)
- nonhuman-primates (1)
- normal distribution (1)
- norway spruce (1)
- nuclear envelope (1)
- nuclear pore complex (1)
- nucleotide-gated channel (1)
- odorants (1)
- oilseed rape (1)
- oncogene amplification (1)
- oncogene-induced senescence (1)
- oncolytic virotherapy (1)
- oncolytic virus therapy (1)
- onkolytische Virustherapie (1)
- optical control (1)
- optical reconstruction microscopy (1)
- organismal evolution (1)
- orthoptera (1)
- osmia (1)
- outer membrane proteins (1)
- ovarian cancer (1)
- ovarian carcinoma (1)
- p38 (1)
- painful (1)
- palynolog (1)
- parasites (1)
- patch connectivity (1)
- pathogen vacuole (1)
- pathogen-host interaction (PHI) (1)
- pathogenicity (1)
- pathways (1)
- performance liquid chromatography (1)
- permeability (1)
- peroxiredoxin 6 (1)
- pest (1)
- pestis infection (1)
- phagosome maturation arrest (1)
- phenology shifts (1)
- phenotypic plasticity (1)
- pheromones (1)
- phosphorylation (1)
- photodynamic therapy (1)
- physiological constraints (1)
- plant diversity (1)
- plant-insect interactions (1)
- plantations (1)
- pneumonic plague (1)
- poeciliid fishes (1)
- pollen (1)
- pollination (1)
- pollination ecology (1)
- populations (1)
- populations genetics (1)
- potential role (1)
- preexisting bias (1)
- preproteins (1)
- presynaptic calcium (1)
- presynaptic differentiation (1)
- principal component analysis (1)
- productivity (1)
- prognostic marker (1)
- proportion of seminatural habitat (1)
- propulsion (1)
- prostaglandin E2 (1)
- protandry (1)
- protein biosynthesis & quality control (1)
- protein complexes (1)
- protein domains (1)
- protein interaction database (1)
- protein interactions (1)
- protein-coupled receptors (1)
- protein-protein interaction (1)
- protein-protein interaction network (1)
- proteomics (1)
- quantification (1)
- rare (1)
- re-annotation (1)
- reactive oxygen (1)
- reactive oxygen species (1)
- recognize images (1)
- recombinant protein rVE (1)
- reconstruction microscopy (1)
- regulation (1)
- regulatory networks (1)
- reporter gene (1)
- resin (1)
- resolution (1)
- retinal differentiation (1)
- reveals (1)
- rhodopsin (1)
- ribosome (1)
- sand dynamics (1)
- secondary rainforest fragments (1)
- sequence alignment (1)
- sequencing data (1)
- serum (1)
- sex chromosome evolution (1)
- sex combs (1)
- sex differentiation (1)
- shear stress (1)
- shootin-1 (1)
- signals (1)
- similarity (1)
- size dimorphism (1)
- skin (1)
- small-colony variants (1)
- snoRNA (1)
- software (1)
- somatic mutations (1)
- specialization (1)
- species richness (1)
- spectrometry-based proteomics (1)
- sperm head formation (1)
- spermatogenesis (1)
- spermiogenesis (1)
- spillover (1)
- spire (1)
- spot size (1)
- stage III (1)
- statistical disperison (1)
- statistics (1)
- strategy (1)
- structure-function relationships (1)
- structured illumination (1)
- substrate quality (1)
- sucrose (1)
- super-resolution microscopy (1)
- sustainable intensification (1)
- swordtails (1)
- synaptic delay (1)
- synaptic transmission (1)
- synaptotagmin (1)
- t-Test (1)
- tag fusion proteins (1)
- tegument protein pUL36 (1)
- teleostei (1)
- temperature (1)
- tonicity (1)
- transcription (1)
- transcription factors (1)
- transcriptional regulation (1)
- transcriptional responses (1)
- transcriptome (1)
- transfer (1)
- transformation (1)
- translational regulation (1)
- trees (1)
- trophic interactions (1)
- tsetse fly (1)
- tumor vascularization (1)
- tumors (1)
- turnover (1)
- type-1 (1)
- ubiquitination (1)
- vaccine (1)
- vaccinia virus (1)
- validation (1)
- variants (1)
- virotherapy (1)
- vision (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (98) (remove)
Sonstige beteiligte Institutionen
ResearcherID
- D-1221-2009 (1)
- N-2030-2015 (1)
Molecular and cellular cross talk between angiogenic, immune and DNA mismatch repair pathways
(2015)
VEGF is a main driver of tumor angiogenesis, playing an important role not only in the formation of new blood vessels, but also acts as a factor for cell migration, proliferation, survival and apoptosis. Angiogenesis is a universal function shared by most solid tumors and its inhibition was thought to have the potential to work across a broad patient population. Clinical evidence has shown that inhibiting pathological angiogenesis only works in a subset of patients and the identification of those patients is an important step towards personalized cancer care. The first approved antiangiogenic therapy was bevacizumab (Avastin®), a monoclonal antibody targeting VEGF in solid tumors including CRC, BC, NSCLC, RCC and others.
In addition to endothelial cells, VEGF receptors are present on a number of different cell types including tumor cells, monocytes and macrophages. The work presented in this thesis looked at the in vitro cellular changes in tumor cells and leukocytes in response to the inhibition of VEGF signaling with the use of bevacizumab. In the initial experiments, VEGF was induced by hypoxia in tumor cells to evaluate changes in survival, proliferation, migration and changes in gene or protein expression. There was a minimal direct response of VEGF inhibition in tumor cells that could be attributed to bevacizumab treatment, with minor variations in some of the cell lines screened but no uniform or specific response noted.
MMR deficiency often results in microsatellite instability (MSI) in tumors, as opposed to microsatellite stable (MSS) tumors, and accounts for up to 15% of colorectal carcinomas (CRCs). It has been suggested in clinical data that MMR deficient tumors responded better to bevacizumab regimens, therefore further research used isogenic paired CRC tumor cell lines (MMR deficient and proficient). Furthermore, a DNA damaging agent was added to the treatment regimen, the topoisomerase inhibitor SN-38 (the active metabolite of irinotecan). Inhibiting VEGF using bevacizumab significantly inhibited the ability of MMR deficient tumor cells to form anchor dependent colonies, however conversely, bevacizumab treatment before damaging cells with SN-38, showed a significant increase in colony numbers. Moreover, VEGF inhibition by bevacizumab pretreatment also significantly increased the mutation fraction in MMR deficient cells as measured by transiently transfecting a dinucleotide repeat construct, suggesting VEGF signaling may have an intrinsic role in MMR deficient cells. A number of pathways were analyzed in addition to changes in gene expression profiles resulting in the identification of JNK as a possible VEGF targeted pathway. JUN expression was also reduced in these conditions reinforcing this hypothesis, however the intricate molecular mechanisms remain to be elucidated.
In order to remain focused on the clinical application of the findings, it was noted that some cytokines were differentially regulated by bevacizumab between MMR proficient and deficient cells. Treatment regimens employed in vitro attempted to mimic the clinical setting by inducing DNA damage, then allowing cells to recover with or without VEGF using bevacizumab treatment. Inflammatory cytokines, CCL7 and CCL8, were found to have higher expression in the MMR deficient cell line with bevacizumab after DNA damage, therefore the cross talk via tumor derived factors to myeloid cells was analyzed. Gene expression changes in monocytes induced by tumor conditioned media showed CCL18 to be a bevacizumab regulated gene by MMR deficient cells and less so in MMR proficient cells. CCL18 has been described as a prognostic marker in gastric, colorectal and ovarian cancers, however the significance is dependent on tumor type. CCL18 primarily exerts its function on the adaptive immune system to trigger a TH2 response in T cells, but is also described to increase non-specific phagocytosis. The results of this study did show an increase in the phagocytic activity of macrophages in the presence of bevacizumab that was significantly more apparent in MMR deficient cells. Furthermore, after DNA damage MMR deficient cells treated with bevacizumab released a cytokine mix that induced monocyte migration in a bevacizumab dependent manner, showing a functional response with the combination of MMR deficiency and bevacizumab. In summary, the work in this thesis has shown evidence of immune cell modulation that is specific to MMR deficient tumor cells that may translate into a marker for the administration of bevacizumab in a clinical setting.
VEGF ist ein zentraler Regulator der Tumor-Angiogenese, und spielt eine wichtige Rolle nicht nur in der Bildung von neuen Blutgefäßen, sondern ist auch für die Migration, Proliferation, das Überleben und Apoptose von Tumorzellen essentiell. Angiogenese ist eine der universellen Funktionen, welche das Wachstum der meisten soliden Tumoren charakterisiert. Eine der klassischen therapeutischen Ideen wurde auf der Basis entwickelt, dass die spezifische Hemmung der Angiogenese das Potenzial hat in einer breiten Patientenpopulation einen klinischen Effekt zu zeigen. Die klinische Erfahrung und Anwendung hat jedoch gezeigt, dass die Hemmung der pathologischen Angiogenese nur in einem Teil der Patienten einen therapeutischen Nutzen aufweist. Somit stellt die Identifikation derjenigen Patienten, welche von der anti-angiogenen Therapie profitieren, einen wichtiger Schritt zur personalisierten Krebsbehandlung dar. Die erste zugelassene antiangiogene Therapie war Bevacizumab (Avastin®), ein monoklonaler Antikörper gegen VEGF, welcher unter anderem in soliden Tumoren wie CRC, BC, nicht-kleinzelligem Lungenkrebs (NSCLC) und dem Nierenzellkarzinom angewandt wird.
VEGF-Rezeptoren befinden sich nicht nur auf Endothelzellen, sondern sind auch auf einer Anzahl von verschiedenen Zelltypen, einschließlich Tumorzellen, Monozyten und Makrophagen nachweisbar. Die in dieser Arbeit vorgestellten Ergebnisse befassen sich mit den zellulären Veränderungen an Tumorzellen und Leukozyten als Reaktion auf die Hemmung der VEGF-Signalkaskade durch Bevacizumab in-vitro. In den Initialen Experimenten wurde VEGF durch Hypoxie in Tumorzellen induziert und Veränderungen der Überlebensrate, der Proliferation, Migration als auch in der Gen- oder Protein-Expression gemessen. Es konnte eine minimale direkte Reaktion der VEGF-Hemmung auf Tumorzellen beobachtet werden, welche auf die Bevacizumab Behandlung zurückgeführt werden könnte. Es zeigten sich aber auch geringfügige Abweichungen in einigen der verwendeten Zellinien, die keine einheitliche Interpretation erlauben oder auf eine uniformelle Reaktion hinweisen würden.
Das phänotypische Korrelat einer „Mismatch“ Reparatur (MMR)-Defizienz ist die Mikrosatelliteninstabilität im Gegensatz zu mikrosatellitenstabilen Tumoren und findet sich bei bis zu 15% der kolorektalen Karzinomen (CRC) wieder. Klinischen Daten deuten daraufhin, dass Bevacizumab besser in MMR-defizienten Tumoren wirkt. Daher wurden die weiteren Untersuchungen in gepaarten MMR stabilen und MMR instabilen CRC-Tumorzelllinien (MMR defizient und kompetent) durchgeführt. Weiterhin wurde ein DNA-schädigendes Agens, SN-38, ein Topoisomerase-Inhibitor (der aktive Metabolit von Irinotecan) dem Behandlungsschema zugefügt. Es zeigte sich, dass die Hemmung von VEGF mittels Bevacizumab die Fähigkeit der MMR defizienten Tumorzellen Kolonien zu bilden signifikant inhibiert. Im Gegensatz dazu, hatte die Behandlung von Bevacizumab vor der Zugabe des DNA schädigenden Agens zu einer vermehrten Kolonienzahl geführt. Außerdem erhöhte die Vorbehandlung mit Bevacizumab deutlich die Mutationsrate in MMR-defizienten Zellen, was durch die transiente Transfektion eines Dinukleotid-Repeat-Konstrukts nachgewiesen werden konnte. Dies deutete darauf hin, dass VEGF eine intrinsische Rolle in der Signalkaskade des MMR-Systems haben könnte. Deshalb wurde eine Anzahl von Signalalkaskaden zusätzlich zu Veränderungen von Genexpressionsprofilen untersucht und JNK als mögliche Verbindungsstelle der beiden Signalkaskaden, VEGF und MMR, identifiziert. Diese Hypothese wurde zusätzlich unterstützt durch die Tatsache, dass die JUN Expression unter diesen experimentellen Bedingungen reduziert war. Die Aufklärung der komplexen molekularen Mechanismen der potentiellen Interaktion bleibt zukünftigen Untersuchungen vorbehalten.
In Hinblick auf die klinische Konsequenz der erhaltenen Ergebnisse war es auffällig, dass einige Zytokine durch Bevacizumab in den MMR defizienten Zellen im Gegensatz zu den MMR kompetenten Zellen unterschiedlich reguliert wurden. Die in-vitro verwendeten Behandlungsschemata waren den klinisch zur Anwendung kommenden Protokollen nachempfunden. Zuerst wurde ein DNA-Schaden gesetzt, und den Zellen ermöglicht, sich mit oder ohne Bevacizumab zu erholen. Es konnte gezeigt werden, dass die inflammatorischen Zytokine CCL7 und CCL8 eine höhere Expression in der MMR-defiziente Zelllinie in Kombination mit Bevacizumab aufweisen. Daher wurde ein möglicher Crosstalk zwischen von Tumorzellen sezernierten Faktoren und myeloischen Zellen weiter verfolgt. Veränderungen der Genexpression in Monozyten durch Tumorzell- konditionierte Medien zeigte CCL18 als ein Bevacizumab reguliertes Gen in MMR-defizienten Zellen, aber nicht in MMR kompetenten Zellen. CCL18 übt seine Funktion primär im adaptiven Immunsystems aus um eine TH2-Antwort in T-Zellen auszulösen Ausserdem wird eine Erhöhung der nicht-spezifische Phagozytose als weitere Funktion beschrieben. CCL18 wurde bereits als prognostischer Marker in Magen-, Dickdarm- und Eierstockkrebsarten beschrieben; die klinische Bedeutung ist jedoch abhängig von Tumortyp.
Die Ergebnisse dieser Arbeit zeigen, dass eine Erhöhung der phagozytischen Aktivität von Makrophagen in Gegenwart von Bevacizumab wesentlich deutlicher in MMR-defizienten Zellen ausgeprägt war. Weiterhin wurde gefunden, dass nach DNA-Schädigung in Bevacizumab behandelten MMR-defizienten Zellen Zytokine freigesetzt werden, welche eine Monozytenmigration in einer Bevacizumab-abhängigen Weise induzieren. Dies weist auf eine funktionelle Interaktion von MMR-Defizienz und Bevacizumab hin. Zusätzlich zeigen die Ergebnisse dieser Arbeit eine Immunzellmodulation, die spezifisch für Mismatch-Reparatur defiziente Tumorzellen ist und in der klinischen Praxis als Marker für die Verabreichung von Bevacizumab verwendet werden könnte.